Thyroid

Featured Article

Subclinical Hypothyroidism: Controversies in Testing and Treatment

Subclinical Hypothyroidism: Controversies in Testing and Treatment

Divergent recommendations in guidelines from the USPSTF and the ATA/AACE contribute to the controversy surrounding whether to test and treat for subclinical hypothyroidism.

Latest

Hypoparathyroidism Associated With Chronic Health Conditions, Increased Mortality

Hypoparathyroidism Associated With Chronic Health Conditions, Increased Mortality

Patients with hypoparathyroidism have increased risk for several health conditions including cataracts, epilepsy, cardiovascular disease, cerebrovascular disease, infection, mental illness, and renal failure.

Hypothyroidism Treatment No Longer Available

Hypothyroidism Treatment No Longer Available

The manufacturing discontinuation was a business decision made by the Company.

Patients Undergoing Thyroid Surgery May Require Few Opioids

Patients Undergoing Thyroid Surgery May Require Few Opioids

Patients undergoing thyroid and parathyroid surgery may require few to no opioid medications postoperatively.

High Free T4 Levels Within Reference Range Associated With Atrial Fibrillation

High Free T4 Levels Within Reference Range Associated With Atrial Fibrillation

Higher levels of free T4 that remain within the reference range are associated with a greater prevalence and incidence of atrial fibrillation.

Genetic Test Helps Differentiate Benign vs Malignant Thyroid Nodules

Genetic Test Helps Differentiate Benign vs Malignant Thyroid Nodules

A multigene genomic classifier (GC) test for thyroid nodules with indeterminate cytology shows high sensitivity and negative predictive value.

FDA Approves Marketing of 2 Devices to Detect Parathyroid Tissue in Real Time

FDA Approves Marketing of 2 Devices to Detect Parathyroid Tissue in Real Time

Fluobeam 800 and the PTeye System were both reviewed under the FDA's de novo premarket review pathway, which oversees approval of low- to moderate-risk novel devices.

Etelcalcetide Found to Increase BMD in Secondary Hyperparathyroidism

Etelcalcetide Found to Increase BMD in Secondary Hyperparathyroidism

Markers of bone resorption decreased in hemodialysis patients with 6 months of etelcalcetide treatment.

Thrice-Weekly Calcimimetic Dosing Feasible for Patients on Hemodialysis With Hyperparathyroidism

Thrice-Weekly Calcimimetic Dosing Feasible for Patients on Hemodialysis With Hyperparathyroidism

In a study, patients receiving cinacalcet under supervision 3 times per week after dialysis rather than after daily self-administration showed improvement in their parathyroid hormone levels.

Autoimmune Thyroid Disease Associated With Onset of Rheumatoid Arthritis

Autoimmune Thyroid Disease Associated With Onset of Rheumatoid Arthritis

Rheumatoid arthritis is associated with an increased occurrence of autoimmune thyroid disease, indicated by an increased risk of developing autoimmune thyroid disease before RA diagnosis.

Preventing Unnecessary Thyroid Biopsies: A Comparison of 5 Sonographic Risk Stratification Systems

Preventing Unnecessary Thyroid Biopsies: A Comparison of 5 Sonographic Risk Stratification Systems

The best overall performance was that of the ACR Thyroid Imaging Reporting and Data System, which classified more than half of the requested biopsies as unnecessary.

Sign Up for Free e-Newsletters



CME Focus